• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP 2.33% 21.0¢

CYNATA THERAPEUTICS LIMITED

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYP 13:59 11 1.8K
13:59 Last post  JB1975 Comments Created with Sketch.  11  Views Created with Sketch.  1.8K 
CYP 22/08/24 612 114K
22/08/24 Last post  JB1975 Comments Created with Sketch.  612  Views Created with Sketch.  114K 
CYP 19/08/24 0 213
19/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  213 
CYP 19/08/24 0 167
19/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
CYP 18/08/24 15 3.1K
18/08/24 Last post  gavint66 Comments Created with Sketch.  15  Views Created with Sketch.  3.1K 
CYP 18/08/24 45 8.4K
18/08/24 Last post  Pledge Comments Created with Sketch.  45  Views Created with Sketch.  8.4K 
CYP 17/08/24 7 2.1K
17/08/24 Last post  flotsam222 Comments Created with Sketch.  7  Views Created with Sketch.  2.1K 
CYP
GVHD Clinical trial record updated
14/08/24 1 447
14/08/24 Last post  Pledge Comments Created with Sketch.  1  Views Created with Sketch.  447 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - CYP
19 Aug 17:14
 
Appendix 3Y - Dr Kilian Kelly
19 Aug 08:27
 
Notification of cessation of securities - CYP
19 Aug 08:22
 
Cynata to Present at ISCT Meeting
09 Aug 09:12
 
Study of Cymerus MSCs in Pulmonary Fibrosis Published
08 Aug 09:49
 
Cleansing Notice
31 Jul 12:11
 
View More arrow Created with Sketch.
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $37.91M
Open High Low Value Volume
21.0¢ 21.0¢ 20.5¢ $11.26K 53.68K

Buyers (Bids)

No. Vol. Price($)
1 7339 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 32225 2
View Market Depth
Last trade - 15.39pm 23/08/2024 (20 minute delay) ?
Last
21.5¢
  Change
-0.005 ( 2.27 %)
Open High Low Volume
20.0¢ 21.5¢ 20.0¢ 2671
Last updated 15.42pm 23/08/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.